Rotavirus

In this video, Uma Mahadevan, MD, director of the Colitis and Crohn’s Disease Center at the University of California, San Francisco, spoke with Healio about a consensus conference on the management of IBD in pregnancy.

TORONTO — Rotavirus vaccination is not associated with significant outbreaks of the disease in NICUs, according to a study presented at the Pediatric Academic Societies Meeting.

Children who are hospitalized for rotavirus demonstrate a higher risk for developing juvenile-onset autoimmune diseases, including inflammatory arthritis and vasculitis, according to data published in JAMA Network Open.

Infants who have been exposed to tumor necrosis factor inhibitors in utero should receive the rotavirus vaccine in the first 6 months of life, according to new recommendations from the American College of Rheumatology.

The use of a three-dose, monovalent oral rotavirus vaccine — Rotavac (Bharat Biotech International) — was not associated with an increased risk for intussusception during a 3-year trial in India.

Experts are developing and testing numerous vaccine candidates against norovirus, which causes hundreds of millions of infections each year worldwide and is seen as a top target for vaccine research. Infectious Disease News asked Xavier Sáez-Llorens, MD, principal investigator for Cevaxin, a vaccines and clinical research center in Panama, which norovirus vaccine or vaccine approach holds the most promise.